Mar 13
2018
CROWNBIO ENTERS STRATEGIC PARTNERSHIP WITH PHANES THERAPEUTICS TO ACCELERATE DISCOVERY AND DEVELOPMENT OF PHANES’ NOVEL ONCOLOGY AGENTS
Original link: https://blog.crownbio.com/press/partnership-with-phanes (San Diego, Calif., March 13, 2018) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:...
Read More
Dec 14
2017
WUXI BIOLOGICS AND PHANES ANNOUNCE STRATEGIC PARTNERSHIP
Shanghai and San Diego, Dec. 14, 2017 — WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering...
Read More
